Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Granules India
Manufacturing
Granules hit with FDA warning letter over production woes
Shortly after making an M&A play to break into the CDMO business, Granules’ manufacturing bona fides have come under fire in a new FDA warning letter.
Fraiser Kansteiner
Mar 5, 2025 8:38am
Granules buys Senn Chemicals for $22M to enter peptides biz
Feb 24, 2025 8:38am
Granules receives Form 483 over poor document controls and more
Sep 19, 2024 10:11am
FDA issues Granules India 3 observations after inspection
Jan 31, 2022 10:20am
Marksans dramatically expands metformin recall on NDMA scare
Oct 5, 2020 6:18pm
Sun Pharma recalls metformin after carcinogen test
Sep 23, 2020 10:45am